Anna Paula Azevedo de Carvalho

Dr. Anna Paula Azevedo de Carvalho

Chemistry Institute, Department of biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2022 in Comprehensive Reviews in Food Science and Food Safety
Verified
Journal Article
Closed access
Italo Rennan Sousa VieiraItalo Rennan Sousa Vieira
Italo Rennan Sousa Vieira
Anna Paula Azevedo de CarvalhoAnna Paula Azevedo de Carvalho
Anna Paula Azevedo de Carvalho
CCCarlos Adam Conte‐Junior
Carlos Adam Conte‐Junior


1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
CVCarla Paulo Vieira
Carla Paulo Vieira
Iuri Lima dos Santos RosarioIuri Lima dos Santos Rosario
Iuri Lima dos Santos Rosario
CLCarini Lelis
Carini Lelis
BRBruna Samara S. Rekowsky
Bruna Samara S. Rekowsky
Anna Paula Azevedo de CarvalhoAnna Paula Azevedo de Carvalho
Anna Paula Azevedo de Carvalho
CCCarlos A. Conte-Junior
Carlos A. Conte-Junior
Despite evidence of health benefits from kefir administration, a systematic review with meta‐analysis on bioactive compounds associated with these benefits is still absent in the literature. Kefir is fermented milk resulting from the metabolism of a complex microbiota in symbiosis. Recent researches have investigated the bioactive compounds responsible for the preventive and therapeutic effects attributed to kefir. However, differences in functional potential between industrial and artisanal kefir are still controversial. Firstly, we identified differences in the microbial composition among both types of kefir. Available evidence concerning the action of different bioactive compounds from kefir on health, both from in vitro and in vivo studies, was subsequently summarized to draw a primary conclusion of the dose and the intervention time for effect, the producer microorganisms, the precursor in the milk, and the action mechanism. Meta‐analysis was performed to investigate the statistically significant differences (P < 0.05) between intervention and control and between both types of kefir for each health effect studied. In summary, the bioactive compounds more commonly reported were exopolysaccharides, including kefiran, bioactive peptides, and organic acids, especially lactic acid. Kefir bioactive compounds presented antimicrobial, anticancer, and immune‐modulatory activities corroborated by the meta‐analysis. However, clinical evidence is urgently needed to strengthen the practical applicability of these bioactive compounds. The mechanisms of their action were diverse, indicating that they can act by different signaling pathways. Still, industrial and artisanal kefir may differ regarding functional potential—OR of 8.56 (95% CI: 2.27–32.21, P ≤ .001)—according to the observed health effect, which can be associated with differences in the microbial composition between both types of kefir.

22 October 2023 in Fermentation
Verified
Journal Article
Open access
PDF file
DFDOUGLAS FARIA
DOUGLAS FARIA
Anna Paula Azevedo de CarvalhoAnna Paula Azevedo de Carvalho
Anna Paula Azevedo de Carvalho
CCCarlos Adam Conte-Junior
Carlos Adam Conte-Junior
Significant amounts of fermented food waste are generated worldwide, promoting an abundance of residual biomass that can be used as raw material to extract bioactive peptides, fermentable sugars, polyphenols, and valuable compounds for synthesizing bioproducts. Therefore, generating these high-value-added products reduces the environmental impact caused by waste disposal and increases the industrial economic value of the final products. This review presents opportunities for synthesizing bioproducts and recovering bioactive compounds (employing wastes and byproducts from fermented sources) with several biological properties to support their consumption as dietary supplements that can benefit human health. Herein, the types of fermented food waste and byproducts (i.e., vegetables, bread wastes, dairy products, brewing, and winery sources), pre-treatment processes, the methods of obtaining products, the potential health benefits observed for the bioactive compounds recovered, and other technological applications of bioproducts are discussed. Therefore, there is currently a tendency to use these wastes to boost bioeconomic policies and support a circular bioeconomy approach that is focused on biorefinery concepts, biotechnology, and bioprocesses.

22 February 2021 in Global Challenges
Verified
Journal Article
Open access
PDF file
Anna Paula Azevedo de CarvalhoAnna Paula Azevedo de Carvalho
Anna Paula Azevedo de Carvalho
CCCarlos A. Conte‐Junior
Carlos A. Conte‐Junior
The current pandemic of coronavirus disease 2019 (COVID‐19) is recognized as a public health emergency of worldwide concern. Nanomaterials can be effectively used to detect, capture/inactivate or inhibit coronavirus cell entry/replication in the human host cell, preventing infection. Their potential for nanovaccines, immunoengineering, diagnosis, repurposing medication, and disinfectant surfaces targeting the novel coronavirus (SARS‐CoV‐2) is highlighted. In this systematic review the aim is to present an unbiased view of which and how nanomaterials can reduce the spread of COVID‐19. Herein, the focus is on SARS‐CoV‐2, analyzing 46 articles retrieved before December 31, 2020. The interface between nanomaterials is described, and the main mechanisms to inhibit SARS‐CoV‐2 pathogenesis and viral inactivation are also discussed. Nanocarbons, biopolymeric, copper, and silver nanoparticles are potential antiviral and virucidal agents toward self‐cleaning and reusable filter media and surfaces (e.g., facial masks), drug administration, vaccines, and immunodiagnostic assays. Trends in toxicology research and safety tests can help fill the main gaps in the literature and overcome health surveillance's challenges. Phytochemicals delivery by nanocarriers also stand out as candidates to target and bio‐friendly therapy. Nanocellulose might fill in the gaps. Future research using nanomaterials targeting novel therapies/prophylaxis measures to COVID‐19 and future outbreaks is discussed.

5 May 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
VRVinicius Rossa
Vinicius Rossa
LFLuanne Ester Monteiro Ferreira
Luanne Ester Monteiro Ferreira
SVSancler da Costa Vasconcelos
Sancler da Costa Vasconcelos
ESEric Thomas Tai Shimabukuro
Eric Thomas Tai Shimabukuro
VMVinicius Gomes da Costa Madriaga
Vinicius Gomes da Costa Madriaga
TLThiago Lima
Thiago Lima
Food packaging based on nanotechnology of polymeric nanocomposites of graphene and graphene oxide results in packaging with better thermal, mechanical, antimicrobial, electrical packaging, moisture barrier and gas properties.